Policies to Impact

GHIAA is a global resource providing research, education, advocacy and support to stakeholders involved with global health agreements and related policies. Click below to access the GHIAA MAPGuide, a curated collection of actual and template contractual provisions from global health alliance agreements.

The Global Healthcare Innovation Alliance Accelerator (GHIAA)

We are dedicated to improving the health of the world’s communities through accelerated and improved alliance formation.

The  Global Healthcare Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

global_healt_rep_david_price510 (1)

The  Global Healthcare Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

global_healt_rep_david_price510 (1)
global_healt_rep_david_price510 (1)

The  Global Healthcare Innovation Alliance Accelerator (GHIAA), established in 2017, is an independent resource, curator, interdisciplinary think tank, and consultancy. GHIAA aims to facilitate translation of global health policies into actionable agreement provisions that will address global health challenges by advancing research, development and marketing for new biomedical technologies. To achieve this objective, GHIAA develops and promotes the use of tools and best practices for global health alliance formation. We seek to engage academic, governmental, business, and nonprofit organizations in this collaborative effort. 

Launch of the MAPGuide

We are excited to announce the launch of the GHIAA Master Alliance Provisions Guide (MAPGuide). The MAPGuide is a new tool to help practitioners and policymakers access a curated collection of actual and template contractual provisions from global health agreements that address key principles upon which partnerships are built. The MAPGuide will be updated regularly, and we are seeking additional content in the form of full agreements or individual agreement provisions.

Latest News

  • September 13, 2022

    Board Member to Present at WIPF

    GHIAA Board member Ana Santos Rutschman will be presenting “The Role of Intellectual Property in Achieving Global Health Security” at the World Intellectual Property Forum in Bangkok on October 12, 2022, 9:00am local time. Read More
  • September 12, 2022

    Julie Barnes-Weise to present at LES Annual Meeting

    On October 18, 2022 at 2:15 PST, Julie will be participating in a session at the Licensing Executives Society (U.S.A. and Canada), Inc. (LES) Annual Meeting entitled, “Working with Funders and International Organizations to Access Non-Traditional Global Markets.” Full Agenda Here
  • August 30, 2022

    GHIAA ED to Speak at Harvard Law

    Julie has been invited to speak at Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics in a panel titled, “Creating Sustainable Infrastructure for Pandemic Preparedness and Response“ along with participants from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, the Harvard University Kennedy School of Government, Ginkgo Bioworks, Inc., and University of Massachusetts Lowell. This is a virtual event taking place at 12:30 EDT on September 14, 2022, and registration is currently open. Register Here
  • May 26, 2022

    New Article in Think Global Health: Building COVID-19 Vaccine Production Capacity in LMICs

    Authors Reid Adler, Julia Barnes-Weise, Ana Santos Rutschman, and Bridie Telford have published a new article in Think Global Health exploring the potential obstacles created by vaccine patents. The piece includes a table listing the LMICs in which there are active patent filings for the 13 vaccines tracked in VaxPaL, the Medicines Patent Pool on-line database of information on the patent status of COVID-19 vaccines worldwide. Read More